Angiodynamic 

€10.1
19
+€0.3+3.06% Wednesday 19:55

統計

當日最高
9.9
當日最低
9.75
52週高點
11.6
52週低點
7
成交量
-
平均成交量
-
市值
416.29M
本益比
-
股息殖利率
-
股息
-

即將到來

財報

2Apr預期
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-0.15
-0.1
-0.05
0
預期EPS
-0.11
實際EPS
-0.07

財務

-11.61%利潤率
未盈利
2019
2020
2021
2022
2023
2024
527.64M營收
-61.26M淨利

其他人也在關注

此清單是根據在 Stock Events 上追蹤 UG2.F 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. The company's thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit for use in extracorporeal circulatory support procedures for periods of up to six hours, as well as with other manufacturers' off-the-shelf pump, filter, and reinfusion cannula facilitate venous drainage. It also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, diagnostic and interventional guidewires, and coaxial micro-introducer kits for use in peripheral diagnostic and interventional procedures. In addition, the company provides abscession drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-access kits offer interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero Microwave Tissue Ablation System includes solero microwave generator and the solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.
Show more...
執行長
Mr. James C. Clemmer
員工
675
國家
US
ISIN
US03475V1017
WKN
000A0B9A5

上市

0 Comments

分享你的想法

FAQ

Angiodynamic 今天的股價是多少?
UG2.F 目前價格為 €10.1 EUR,過去 24 小時上漲了 +3.06%。在圖表上更密切關注 Angiodynamic 股價表現。
Angiodynamic 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Angiodynamic 的股票以代號 UG2.F 進行交易。
Angiodynamic 的股價在上漲嗎?
UG2.F 股票較上週上漲 +3.59%,本月上漲 +4.12%,過去一年 Angiodynamic 上漲 +2.02%。
Angiodynamic 的市值是多少?
今天 Angiodynamic 的市值為 416.29M
Angiodynamic 去年的營收是多少?
Angiodynamic 去年的營收為 527.64MEUR。
Angiodynamic 去年的淨利是多少?
UG2.F 去年的淨收益為 -61.26MEUR。
Angiodynamic 有多少名員工?
截至 April 02, 2026,公司共有 675 名員工。
Angiodynamic 位於哪個產業?
Angiodynamic從事於Health Care產業。
Angiodynamic 何時完成拆股?
Angiodynamic 最近沒有進行任何拆股。
Angiodynamic 的總部在哪裡?
Angiodynamic 的總部位於 US 的 Latham。